Salamanca Auditorium (Hall 3) ESMO Colloquium

ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)

Date
30.09.2019
Time
18:30 - 20:00
Location
Salamanca Auditorium (Hall 3)
Chairs
  • Emilie Le Rhun (Lille, CEDEX, France)
  • Matthias Preusser (Vienna, Austria)
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Introduction (ID 6219)

Lecture Time
18:30 - 18:33
Speakers
  • Matthias Preusser (Vienna, Austria)
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Present standard of care for recurrent glioblastoma (ID 6220)

Lecture Time
18:33 - 18:48
Speakers
  • Emilie Le Rhun (Lille, CEDEX, France)
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Q&A (ID 6249)

Lecture Time
18:48 - 18:53
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Novel systemic treatment approaches for recurrent glioblastoma (ID 6221)

Lecture Time
18:53 - 19:13
Speakers
  • Matthias Preusser (Vienna, Austria)
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Q&A (ID 6250)

Lecture Time
19:13 - 19:18
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Biology of CD95/Fas/CD95L (ID 6222)

Lecture Time
19:18 - 19:33
Speakers
  • Michael Weller (Zurich, Switzerland)
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Q&A (ID 6251)

Lecture Time
19:33 - 19:38
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

CD95L/Fas ligand selective inhibition: Rationale and clinical results (ID 6223)

Lecture Time
19:38 - 19:53
Speakers
  • Wolfgang Wick (Heidelberg, Germany)
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Q&A (ID 6252)

Lecture Time
19:53 - 19:58
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities ESMO Colloquium

Conclusions (ID 6224)

Lecture Time
19:58 - 20:00
Speakers
  • Emilie Le Rhun (Lille, CEDEX, France)
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00